Veru Inc
NASDAQ:VERU
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

  • LAST PRICE
    0.8261
  • TODAY'S CHANGE (%)
    -0.0088 (-1.0540%)
  • Bid / Lots
    0.8201/ 1
  • Ask / Lots
    0.8300/ 1
  • Open / Previous Close
    0.8500 / 0.8349
  • Day Range
    0.8160
    0.8512
  • 52 Week Range
    0.3600
    1.9200
  • Volume
    570,585

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Sep 11, 2024

      Show headlines and story abstract

    • 8:30AM ET on Wednesday Sep 11, 2024 by Dow Jones
      Companies Mentioned: VERU

      securities litigation; the Company's ability to identify, successfully negotiate and complete suitable acquisitions or other strategic initiatives; the Company's ability to successfully integrate acquired businesses, technologies or products; and other risks detailed from time to time in the Company's press releases, shareholder communications and Securities and Exchange Commission filings, including the Company's Form 10-K for the year ended September 30, 2023, as amended by the Form 10-K/A, and subsequent quarterly reports on Form 10-Q. These documents are available on the "SEC Filings" section of our website at www.verupharma.com/investors.